CX Partners-led investor consortium completed the acquisition of a controlling stake in Sabine Hospital and Research Centre for $50m.

CX Partners-led investor consortium, including Hero Enterprise and Tanas Capital, completed the acquisition of a controlling stake in Sabine Hospital and Research Centre for $50m. "Sabine Hospital and Research Centre provides accessible healthcare at affordable costs. Their world-class fertility treatments cater to the growing medical needs of people. While upholding the utmost ethical standards and clinical excellence, the organisation has demonstrated remarkable growth, with a CAGR of 25% over the last three years. We see the potential in further expanding Sabine Hospitals to adjacent markets, drawing upon our experience investing in healthcare, attracting high quality professional leadership, and putting in place systems to manage growth," Vivek Chhachhi, CX Partners Managing Partner.